ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $303,527 | +112735.3% | 91,700 | +11.4% | 0.00% | 0.0% |
| Q1 2024 | $269 | -12.4% | 82,300 | -5.9% | 0.00% | 0.0% |
| Q4 2023 | $307 | +95.5% | 87,500 | +270.8% | 0.00% | 0.0% |
| Q3 2023 | $157 | -20.7% | 23,600 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $198 | -99.7% | 23,600 | -20.5% | 0.00% | – |
| Q1 2020 | $73,000 | -57.6% | 29,700 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $172,000 | -44.9% | 29,700 | -50.0% | 0.00% | 0.0% |
| Q3 2019 | $312,000 | -27.6% | 59,400 | -17.4% | 0.00% | -50.0% |
| Q2 2019 | $431,000 | -28.6% | 71,900 | +7.5% | 0.00% | -33.3% |
| Q1 2019 | $604,000 | +87.6% | 66,900 | +72.4% | 0.00% | +50.0% |
| Q4 2018 | $322,000 | +403.1% | 38,800 | +725.5% | 0.00% | – |
| Q3 2018 | $64,000 | +73.0% | 4,700 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,877,305 | $10,025,000 | 5.86% |
| Prosight Management, LP | 1,210,800 | $6,466,000 | 3.46% |
| Perceptive Advisors | 11,350,085 | $60,609,000 | 1.76% |
| JOHNSON & JOHNSON | 394,834 | $2,108,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $3,738,000 | 0.46% |
| APOGEM CAPITAL LLC | 85,091 | $454,000 | 0.45% |
| 683 Capital Management, LLC | 700,000 | $3,738,000 | 0.29% |
| EAM Investors, LLC | 233,638 | $1,248,000 | 0.27% |
| Verition Fund Management LLC | 4,804,478 | $12,840,828 | 0.14% |
| WOODSTOCK CORP | 129,179 | $690,000 | 0.10% |